Article
Targeting Smurf1 to block PDK1-Akt signaling in KRAS-mutated colorectal cancer.
Nature chemical biology - 1 Jan 2025
Peng Zhiqiang, Fang Wei, Wu Bo, He Ming, Li Shaohua, Wei Jun, Hao Yang, Jin Lujia, Liu Mingqiu, Zhang Xin, Wei Yange, Ge Yingwei, Wei Yinghua, Qian Haili, Zhang Yangjun, Jiang Junyi, Chang Zhijie, Rao Yu, Zhang Xueli, Cui Chun-Ping, Zhang Lingqiang
Abstract excerpt
The phosphoinositide 3-kinase (PI3K)-Akt axis is one of the most frequently activated pathways and is demonstrated as a therapeutic target in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutated colorectal cancer (CRC). Targeting the PI3K-Akt pathway has been a challenging undertaking through the decades. Here we unveiled an essential role of E3 ligase SMAD ubiquitylation regulatory factor 1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
